Your gift is 100% tax deductible
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Your gift enables us to support people with cancer and fund research breakthroughs.
The amount must be greater than or equal to $5
Your gift is 100% tax deductible
A risk factor is anything that increases your chance of getting a disease such as cancer. Different cancers have different risk factors. Some cancer risk factors, like smoking, you can change. Others, like your age or family history, can’t be changed.
But having a risk factor, or even several, does not always mean that a person will get the disease, and many people with cancer have few or no known risk factors.
There are several known risk factors for myelodysplastic syndromes (MDS).
MDS can occur at any age, even in children. But it is uncommon in people younger than 50, and it’s most often diagnosed in people in their 70s or 80s.
MDS is more common in men than in women. The reason for this is not clear, although it might have to do with men having been more likely to smoke or to have been exposed to certain chemicals in the workplace in the past.
People who have been treated with certain chemotherapy (chemo) drugs or with radiation therapy for cancer are more likely to develop MDS later. When MDS is caused by cancer treatment, it is called secondary MDS or treatment-related MDS.
People who have had stem cell transplants (bone marrow transplants) can also develop MDS because of the very high doses of chemo (and possibly radiation) they received.
Still, only a small percentage of people who get chemo and radiation will eventually develop MDS.
Smoking increases the risk of MDS. Many people know that smoking can cause lung cancer, but it can also cause cancer in other parts of the body that don't come into direct contact with smoke. Cancer-causing substances in tobacco smoke are absorbed into the blood as it passes through the lungs. Once in the bloodstream, these substances spread to many parts of the body.
Some environmental exposures have been linked to MDS. For example:
People with certain inherited syndromes are more likely to develop MDS. These syndromes are caused by changes (mutations) in genes that are passed down from one or both parents. Examples include:
Many of these rare conditions are linked with MDS that develops during childhood.
In some families without these syndromes, MDS occurs more often than would be expected. Sometimes this is because of a known gene mutation that runs in the family, but in other cases the cause isn’t clear.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Aster JC, Stone RM. Clinical manifestations, diagnosis, and classification of myelodysplastic syndromes (MDS). UpToDate. 2024. Accessed at https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-classification-of-myelodysplastic-syndromes-mds on June 28, 2024.
Churpek JE, Godley LA. Familial disorders of acute leukemia and myelodysplastic syndromes. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/familial-disorders-of-acute-leukemia-and-myelodysplastic-syndromes on June 28, 2024.
National Cancer Institute. Myelodysplastic Syndromes Treatment (PDQ®)–Health Professional Version. 2022. Accessed at https://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq on June 28, 2024.
SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2024 Apr 17. [updated: 2024 Jun 27; cited 2024 Jun 27]. Accessed at https://seer.cancer.gov/statistics-network/explorer/ on June 28, 2024.
Steensma DP, Stone RM. Chapter 96: Myelodysplastic syndromes. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
Zhang Y, LeBeau MM. Cytogenetics, molecular genetics, and pathophysiology of myelodysplastic syndromes/neoplasms (MDS). UpToDate. 2024. Accessed at https://www.uptodate.com/contents/cytogenetics-molecular-genetics-and-pathophysiology-of-myelodysplastic-syndromes-neoplasms-mds on June 28, 2024.
Last Revised: November 21, 2024
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
We fund research breakthroughs that save lives. Your year-end gift helps find new treatments for cancer.